Mono-Sanorania en es it fr

Mono-Sanorania Brand names, Mono-Sanorania Analogs

Mono-Sanorania Brand Names Mixture

  • No information avaliable

Mono-Sanorania Chemical_Formula


Mono-Sanorania RX_link

Mono-Sanorania fda sheet

Mono-Sanorania msds (material safety sheet)

Mono-Sanorania MSDS

Mono-Sanorania Synthesis Reference

Hayward et al., Can.J.Chem., 45; 2191-2192 (1967)

Mono-Sanorania Molecular Weight

191.139 g/mol

Mono-Sanorania Melting Point


Mono-Sanorania H2O Solubility

1.07E+005 mg/L

Mono-Sanorania State


Mono-Sanorania LogP


Mono-Sanorania Dosage Forms

Tablet (immediate release); Tablet (extended release)

Mono-Sanorania Indication

For the prevention of angina pectoris due to coronary artery disease and the treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction.

Mono-Sanorania Pharmacology

Isosorbide-5-mononitrate, the long-acting metabolite of isosorbide dinitrate, is used as a vasodilatory agent in the management of angina pectoris. By dilating the vessels, it lowers the blood pressure and reduces the left ventricular preload and afterload, therefore, leads to a reduction of myocardial oxygen requirement.

Mono-Sanorania Absorption


Mono-Sanorania side effects and Toxicity

Symptoms of overdose include vasodilatation, venous pooling, reduced cardiac output, and hypotension. LD50=mg/kg(orally in rat)

Mono-Sanorania Patient Information

Mono-Sanorania Organisms Affected

Humans and other mammals